x
Filter:
Filters applied
- Editor's Choice
Publication Date
Please choose a date range between 2014 and 2023.
Author
- Denniss, A Robert4
- Gregory, Ann T4
- Kritharides, Leonard4
- Walters, Darren L4
- Bennetts, Jayme3
- Brown, Alex3
- Chow, Clara K3
- Hammett, Christopher3
- MacIsaac, Andrew3
- Meredith, Ian T3
- Anderson, Robert D2
- Bannon, Paul2
- Brieger, David2
- Briffa, Tom2
- Celermajer, David S2
- Chew, Derek2
- French, John K2
- Holland, David J2
- Mooney, John2
- Neubeck, Lis2
- Adlakha, Deepti1
- Ahliah, Ibrahim1
- Ahmar, Wally1
- Al-Omary, Mohammed1
- Albert, Christine M1
Keyword
- COVID-196
- Heart failure5
- Acute coronary syndrome4
- Arterial stiffness4
- Atrial fibrillation4
- Australia4
- Cardiac surgery4
- Cardiovascular diseases4
- Catheter ablation4
- Meta-analysis4
- Percutaneous coronary intervention4
- Prevention4
- Ageing3
- Cardiovascular disease3
- Chest pain3
- Coronary artery disease3
- Sudden cardiac death3
- Aortic stenosis2
- CABG2
- Cardiac rehabilitation2
- Cardiomyopathy2
- Cardiothoracic2
- Echocardiography2
- Epidemiology2
- Ischaemic heart disease2
Editor's Choice
91 Results
- Review
Opportunities and Challenges of Computed Tomography Coronary Angiography in the Investigation of Chest Pain in the Emergency Department—A Narrative Review
Heart, Lung and CirculationVol. 32Issue 3p307–314Published online: January 6, 2023- Manuja Premaratne
- Gloria Patricia Garcia
- William Thomas
- Shaiq Hameed
- Ashley Leadbeatter
- Nay Htun
- and others
Cited in Scopus: 0Chest pain is one of the most common presentations to emergency departments. However, only 5.1% will be diagnosed with an acute coronary syndrome, representing considerable time and expense in the diagnosis and investigation of the patients eventually found not to be suffering from an acute coronary syndrome. PubMed and Medline databases were searched with variations of the terms “chest pain”, “emergency department”, “computed tomography coronary angiography”. After review, 52 articles were included. - Original Article
A Single-Centre Retrospective Review of Modified Blalock-Taussig Shunts: A 22-Year Experience
Heart, Lung and CirculationVol. 32Issue 3p405–413Published online: January 6, 2023- Adrian Tarca
- Giulia Peacock
- Elizabeth McKinnon
- David Andrews
- Jelena Saundankar
Cited in Scopus: 0This single-centre retrospective study explores demographics and outcomes of patients who underwent a modified Blalock-Taussig shunt (MBTS) over a 22-year period. The predominant surgical approach in this study is a lateral thoracotomy, in contrast to a midline sternotomy. Risks and outcomes of this approach are compared with national and international literature. - Original Article
Need and Interest in Nature Prescriptions to Protect Cardiovascular and Mental Health: A Nationally-Representative Study With Insights for Future Randomised Trials
Heart, Lung and CirculationVol. 32Issue 1p114–123Published online: December 30, 2022- Thomas Astell-Burt
- J. Aaron Hipp
- Birgitta Gatersleben
- Deepti Adlakha
- Melissa Marselle
- Katarzyna Olcoń
- and others
Cited in Scopus: 1“Nature prescriptions” are increasingly being adopted by health sectors as an adjunct to standard care to attend to health and social needs. We investigated levels of need and interest in nature prescriptions in adults with cardiovascular diseases, psychological distress and concomitants (e.g. physical inactivity, sedentary behaviour, obesity, loneliness, burn-out). - Editorial
First European Society of Cardiology Cardio-Oncology Guidelines: A Big Leap Forward for an Emerging Specialty
Heart, Lung and CirculationVol. 31Issue 12p1563–1567Published in issue: December, 2022- Mark T. Nolan
- Louise Creati
- Bogda Koczwara
- Leonard Kritharides
- James Lynam
- Alexander R. Lyon
- and others
Cited in Scopus: 0The recent release of the European Society of Cardiology’s Cardio-Oncology guidelines represents a substantial and significant body of scholarly work [1]. These are the first cardio-oncology guidelines to be published by a large multi-national cardiovascular professional society (in collaboration with the European Haematology Association and European Society for Therapeutic Radiology and Oncology) and also the first guidelines to be produced through joint partnership between cardiology and oncology multinational associations. - Review
Mind The Gap, Aboriginal and Torres Strait Islander Cardiovascular Health: A Narrative Review
Heart, Lung and CirculationVol. 32Issue 2p136–142Published online: November 4, 2022- Michael McGee
- Lauren Shephard
- Stuart Sugito
- David Baker
- Stephen Brienesse
- Mohammed Al-Omary
- and others
Cited in Scopus: 0Australia’s First Nations Peoples, Aboriginal and Torres Strait Islanders, have reduced life expectancy compared to the wider community. Cardiovascular diseases, mainly driven by ischaemic heart disease, are the leading contributors to this disparity. Despite over a third of First Nations Peoples living in New South Wales, the bulk of the peer-reviewed literature is from Central Australia and Far North Queensland. Regardless of the site of publication, First Nations Peoples are significantly younger at disease onset and have higher rates of comorbidities, in turn driving adverse health events. - Original Article
Long-Term Ambulatory Intravenous Milrinone Therapy in Advanced Heart Failure
Heart, Lung and CirculationVol. 31Issue 12p1630–1639Published online: October 10, 2022- Sandipan Shringi
- Shiksha Joshi
- John M. Suffredini
- Ashley Schenk
- Navin Rajagopalan
- Maya Guglin
Cited in Scopus: 0The role of intravenous (IV) inotropes in the treatment of ambulatory patients with advanced heart failure (HF) remains controversial. - In Memoriam
Brian Fowell Buxton (15/04/1940–20/05/2022)—Outstanding Achievements and Personal Memories
Heart, Lung and CirculationVol. 31Issue 10p1309–1314Published online: September 13, 2022- Jayme Bennetts
- James Tatoulis
- Jaishankar Raman
- Franklin Rosenfeldt
Cited in Scopus: 0Brian F. Buxton, one of Australia's greatest cardiac surgeons, died in May 2022, aged 82 years. In June 2022, a memorial celebration of Brian's life was held in Melbourne, Australia, attended by 550 colleagues and friends from many walks of life—not only “medical people” but also friends involved in Brian's sailing and hiking activities. This Special Article includes an introduction from Professor Jayme Bennetts, President of the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS), an abridged version of a memorial address by Professor James Tatoulis and contributions from two other long-term professional colleagues and personal friends of Buxton, Professor Jaishankar Raman and Professor Franklin Rosenfeldt, founding editor of Heart, Lung and Circulation. - ReviewOpen Access
Use of Cytokine Filters During Cardiopulmonary Bypass: Systematic Review and Meta-Analysis
Heart, Lung and CirculationVol. 31Issue 11p1493–1503Published online: August 27, 2022- Vinci Naruka
- Mohammad Yousuf Salmasi
- Arian Arjomandi Rad
- Nandor Marczin
- George Lazopoulos
- Marco Moscarelli
- and others
Cited in Scopus: 0Cardiac surgery involving cardiopulmonary bypass (CPB) activates an inflammatory response releasing cytokines that are associated with less favourable outcomes. This study aims to compare i) CPB during cardiac surgery (control) versus ii) CPB with haemoadsorption therapy; and assess the effect of adding this therapy in reducing the inflammatory cytokines burden. - Original Article
Ten Years of Percutaneous Pulmonary Valve Implantation in Australia and New Zealand
Heart, Lung and CirculationVol. 31Issue 12p1649–1657Published online: August 26, 2022- Claire M. Lawley
- David Tanous
- Clare O’Donnell
- Benjamin Anderson
- Nicholas Aroney
- Darren L. Walters
- and others
Cited in Scopus: 0This study sought to investigate the characteristics, morbidity (including the rate of infective endocarditis and valve replacement) and mortality of individuals undergoing percutaneous pulmonary valve implantation in Australia and New Zealand since the procedure has been performed. - Original Article
The Impact of the SARS-CoV-2 Virus (COVID-19) Pandemic and the Rapid Adoption of Telehealth for Cardiac Rehabilitation and Secondary Prevention Programs in Rural and Remote Australia: A Multi-Method Study
Heart, Lung and CirculationVol. 31Issue 11p1504–1512Published online: August 17, 2022- Stephanie Champion
- Robyn A. Clark
- Rosy Tirimacco
- Philip Tideman
- Lemlem Gebremichael
- Alline Beleigoli
Cited in Scopus: 0Centre-based cardiac rehabilitation (CR) programs were disrupted and urged to adopt telehealth modes of delivery during the COVID-19 public health emergency. Previously established telehealth services may have faced increased demand. This study aimed to investigate a) the impact of the COVID-19 pandemic on CR attendance/completion, b) clinical outcomes of patients with cardiovascular (CV) diseases referred to CR and, c) how regional and rural centre-based services converted to a telehealth delivery during this time. - Discussion Paper
Environmental Sustainability in the Cardiac Catheter Laboratory
Heart, Lung and CirculationVol. 32Issue 1p11–15Published online: August 11, 2022- Richard Szirt
- Mohammad R. Monjur
- Laurna McGovern
- Kate Charlesworth
- Stephen O’Connor
- James Crofton Weaver
- and others
Cited in Scopus: 2The health care sector contributes to nearly 5% of global carbon emissions with the exponential growth of medical waste posing a significant challenge to environmental sustainability. As the impact of climate change on individuals and population health becomes increasingly more apparent, the health care system’s significant impact on the environment is also raising concerns. Hospitals contribute disproportionately to health care waste with the majority arising from resource intensive areas such as operating theatres and cardiac catheter labs (CCLs). - Original Article
Determining Underlying Mechanisms of Early Vascular Ageing by Clustered Analysis: The African-PREDICT Study
Heart, Lung and CirculationVol. 31Issue 10p1376–1384Published online: July 19, 2022- Ashleigh Craig
- Wayne Smith
- Catharina M.C. Mels
- Yolandi Breet
- Shani Botha-le Roux
- Adriaan Jacobs
- and others
Cited in Scopus: 1Identifying individuals at increased risk of early vascular ageing (EVA) is paramount to inform intervention and prevention strategies and curb the increasing burden of cardiovascular disease. - Original Article
Balancing the Risks of Recurrent Ischaemic and Bleeding Events in a Stable Post ACS Population
Heart, Lung and CirculationVol. 31Issue 10p1349–1359Published online: July 19, 2022- David Brieger
- Derek Chew
- Shaun Goodman
- Christopher Hammett
- Jeffrey Lefkovits
- Omar Farouque
- and others
Cited in Scopus: 0To better guide decisions regarding antithrombotic treatment in individual patients surviving 6 months following an acute coronary syndrome (ACS) by balancing between subsequent recurrent ischaemic and bleeding risk. - Image
Pseudo-Conduction in the Mitral Isthmus After Ablation
Heart, Lung and CirculationVol. 31Issue 9e126–e128Published online: June 24, 2022- Wei-Tso Chen
- Ibrahim Ahliah
- Fa-Po Chung
Cited in Scopus: 0A 56-year-old patient with a history of hypertension, dyslipidaemia, and long-standing atrial fibrillation underwent pulmonary vein isolation, endocardial mitral line ablation, and alcohol ablation of the vein of Marshall in 2018. He complained of palpitation due to recurrent atrial flutter, which was poorly controlled by amiodarone. Therefore, catheter ablation was arranged. Pre-ablation echocardiography showed normal left ventricular ejection fraction and computed tomography demonstrated an enlarged coronary sinus (CS). - Original Article
Cryoablation of Papillary Muscles at Surgery for Malignant Ventricular Arrhythmias Due to Mitral Valve Prolapse
Heart, Lung and CirculationVol. 31Issue 9p1285–1290Published online: June 10, 2022- Jitendra Vohra
- Joseph B. Morton
- John Morgan
- James Tatoulis
Cited in Scopus: 1Mitral valve prolapse (MVP) is relatively common condition and while generally benign a small subset of patient suffers from malignant ventricular arrhythmias (MVA) and sudden cardiac death (SCD). - Original Article
Severe Functional Tricuspid Valve Regurgitation: Predictors of Mortality After Initial Diagnosis
Heart, Lung and CirculationVol. 31Issue 9p1234–1240Published online: June 3, 2022- Perryn Ng
- Robin Cherian
- Siew Pang Chan
- Wern Miin Soo
- William Kong
- Kian Keong Poh
- and others
Cited in Scopus: 0Severe functional tricuspid regurgitation (fTR) is associated with adverse clinical outcomes and remains under-treated. There is recent interest in this disease due to emerging tricuspid valve therapies. However, the timing and selection of patients who may benefit from treatment is uncertain. Risk factors associated with mortality after diagnosis of severe fTR may help guide treatment. - Review
Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis
Heart, Lung and CirculationVol. 31Issue 8p1064–1074Published online: May 25, 2022- Aran Kanagaratnam
- Sohaib A. Virk
- Timmy Pham
- Robert D. Anderson
- Samual Turnbull
- Timothy Campbell
- and others
Cited in Scopus: 1There are differences in substrate and ablation approaches for ventricular tachycardia (VT) in ischaemic (ICM) and non-ischaemic cardiomyopathy (NICM). - Review
Arrhythmias and Their Electrophysiological Mechanisms in Takotsubo Syndrome: A Narrative Review
Heart, Lung and CirculationVol. 31Issue 8p1075–1084Published online: May 10, 2022- Y. Koh
- A. Voskoboinik
- C. Neil
Cited in Scopus: 0Takotsubo syndrome (TTS), an acute and usually reversible condition, is associated with both tachy- and bradyarrhythmias. Such arrhythmias can be life-threatening, e.g. ventricular tachycardia and fibrillation, and associated with cardiac arrest. Others, such as atrioventricular block, persist and require long-term device therapy. In this narrative review, we aim to provide a summary of the current literature on arrhythmias in TTS and their clinical sequelae. - Review
Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination: A Pragmatic Narrative Review to Guide Clinical Practice
Heart, Lung and CirculationVol. 31Issue 7p924–933Published online: April 6, 2022- David J. Holland
- Penni L. Blazak
- Joshua Martin
- Jennifer Broom
- Rohan S. Poulter
- Tony Stanton
Cited in Scopus: 5Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus is likely to remain endemic globally despite widespread vaccination. There is increasing concern for myocardial involvement and ensuing cardiac complications due to COVID-19, however, the available evidence suggests these risks are low. Pandemic publishing has resulted in rapid manuscript availability though pre-print servers. Subsequent article retractions, a lack of standardised definitions, over-reliance on isolated troponin elevation and the heterogeneity of studied patient groups (i.e. - Review
Outcomes of Coronary Artery Bypass Grafting in Patients With Poor Myocardial Viability: A Systematic Review and Meta-Analysis of the Last Decade
Heart, Lung and CirculationVol. 31Issue 7p916–923Published online: March 23, 2022- Varun J. Sharma
- Arman Arghami
- Deepak Kumar Pasupula
- Abdullah Haddad
- Janny Xue Chen Ke
Cited in Scopus: 1Our objective is to assess whether the presence of myocardial viability is a predictor of mortality among patients undergoing coronary artery bypasss grafting (CABG) through a systematic review meta-analysis. - Original Article
Composite Echocardiographic Score to Predict Long-Term Survival Following Myocardial Infarction
Heart, Lung and CirculationVol. 31Issue 6p795–803Published online: February 24, 2022- Anish Krishnan
- Sandhir B. Prasad
- Kristyan B. Guppy-Coles
- David J. Holland
- Christopher Hammett
- Gillian Whalley
- and others
Cited in Scopus: 0Whilst the left ventricular ejection fraction (LVEF) remains the primary echocardiographic measure widely utilised for risk stratification following myocardial infarction (MI), it has a number of well recognised limitations. The aim of this study was to compare the prognostic utility of a composite echocardiographic score (EchoScore) composed of prognostically validated measures of left-ventricular (LV) size, geometry and function, to the utility of LVEF alone, for predicting survival following MI. - Original Article
COVID-19 Pandemic Impact on Percutaneous Coronary Intervention for Acute Coronary Syndromes: An Australian Tertiary Centre Experience
Heart, Lung and CirculationVol. 31Issue 6p787–794Published online: February 11, 2022- John Ramzy
- Catherine A. Martin
- Sonya Burgess
- Robert Gooley
- Sarah Zaman
Cited in Scopus: 0Countries who suffered large COVID-19 outbreaks reported a decrease in acute coronary syndrome (ACS) presentations and percutaneous coronary intervention (PCI). The impact of the pandemic in countries like Australia, with relatively small outbreaks yet significant social restrictions, is relatively unknown. There is also limited and conflicting data regarding the impact on clinical outcomes, symptom-to-door time (STDT) and door-to-balloon time (DTBT). - Original Article
Sex-Specific Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Disease: A Systematic Review and Meta-Analysis
Heart, Lung and CirculationVol. 31Issue 5p658–665Published online: January 12, 2022- Jennifer Y. Zhou
- Emilia Nan Tie
- Danny Liew
- Stephen J. Duffy
- James Shaw
- Antony Walton
- and others
Cited in Scopus: 0To assess whether outcomes following percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) for left main coronary artery (LMCA) disease differ between men and women. - Editorial
Heart, Lung and Circulation in the COVID-19 Era: About COVID-19, Not Just About COVID-19
Heart, Lung and CirculationVol. 30Issue 12p1792–1799Published in issue: December, 2021- Ann T. Gregory
- A. Robert Denniss
Cited in Scopus: 0In March 2020, our world entered the COVID-19 era [1], and we have all since been experiencing waves of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic [2]. The effect of COVID-19 on our populations and health care systems has been, and continues to be, significant. The global pandemic has also affected scientific medical publishing, with an acknowledged disrupting effect, including a faster track to peer review and on-line publication for COVID-19 submissions but with stress on the peer review and publication of non-COVID-19 research [3]. - Original Article
Factors Influencing Cardiac Sympathetic Nervous Function in Patients With Severe Aortic Stenosis: Assessment by 123I-Metaiodobenzylguanidine Myocardial Scintigraphy
Heart, Lung and CirculationVol. 31Issue 5p671–677Published online: November 15, 2021- Kazuhiro Nitta
- Yukihiro Fukuda
- Kosuke Takahari
- Atsushi Takeda
- Tasuku Higashihara
- Yuichi Morita
- and others
Cited in Scopus: 1Numerous studies have shown that 123I-metaiodobenzylguanidine (MIBG) scintigraphy, an index of cardiac sympathetic nervous (CSN) activity, is useful for predicting prognosis in patients with heart failure. However, the factors influencing the CSN activity of patients with severe aortic stenosis (AS) remain unclear.